TRPV Subfamily (TRPV2, TRPV3, TRPV4, TRPV5, and TRPV6) Gene and Protein Expression in Patients with Ulcerative Colitis

Table 2

Sociodemographic characterization of the patients and controls.

Clinical characteristics		Active UC; (28)		Remission UC; (16)		Controls; (25)
			%		%		%
Gender	Male	11	37.9	8	50	8	30.77
	Female	18	62.1	8	50	18	69.23
Age (median, range)		40	(24-72)	47	(16-75)	54	(23-74)
Age at diagnosis (mean, SD)		31	(6-56)	34	(9-66)
Years of evolution (median, range)		6	(1–24)	7	(0-17)
Extent of disease	E1	7	24.1	2	12.5
	E2	2	6.8	1	6.3
	E3	18	62.1	11	68.8
	Not classifiable	2	6.9	2	12.5
Extraintestinal manifestations	Present	10	34.5	9	56.3
	Absent	17	58.6	5	31.3
	Not documented	2	6.9	2	12.5
Clinical course of disease	Initially active	11	37.9	2	12.5
	Intermittent	1	48.2	9	56.3
	Continuous	2	6.9	2	12.5
	Not documented	2	6.9	3	18.8
Medical treatment	5-ASA	26	89.7	9	56.3
	Steroids	7	24.1	3	18.8
	Thiopurines	4	13.8	2	12.5
	Anti-TNFα	1	3.4